Cargando…
New Biopharmaceutical Characteristics of In Situ Systems Based on Poloxamer 407
Thermosensitive systems based on poloxamer 407 are widely used in targeted drug delivery; however, the stability of the phase transition temperature remains insufficiently studied. This article presents the results of a study on the effect of adding polyethylene glycols (PEG) with different molecula...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10379042/ https://www.ncbi.nlm.nih.gov/pubmed/37504387 http://dx.doi.org/10.3390/gels9070508 |
_version_ | 1785079915322802176 |
---|---|
author | Bakhrushina, Elena O. Novozhilova, Elizaveta V. Shumkova, Marina M. Pyzhov, Victor S. Nikonenko, Maria S. Bardakov, Alexander I. Demina, Natalia B. Krasnyuk, Ivan I. Krasnyuk, Ivan I. |
author_facet | Bakhrushina, Elena O. Novozhilova, Elizaveta V. Shumkova, Marina M. Pyzhov, Victor S. Nikonenko, Maria S. Bardakov, Alexander I. Demina, Natalia B. Krasnyuk, Ivan I. Krasnyuk, Ivan I. |
author_sort | Bakhrushina, Elena O. |
collection | PubMed |
description | Thermosensitive systems based on poloxamer 407 are widely used in targeted drug delivery; however, the stability of the phase transition temperature remains insufficiently studied. This article presents the results of a study on the effect of adding polyethylene glycols (PEG) with different molecular weights and some classical gel-forming polymers on the gelation temperature of thermoreversible compositions based on poloxamer 407 in a long-term experiment. The study showed a positive effect of PEG addition with average molecular weights at concentrations of 1.5–2.0%, as well as gelling agents at a concentration below the critical gelation concentration. The proposed rheological test for studying the samples’ adhesion can give an indirect forecast of the composition adhesive rate. Based on the conducted studies, three experimental binary systems based on poloxamer 407 were selected, with the addition of HPMC 0.5%, sodium alginate 0.5%, and PEG 1500 1.5%. These systems are the most promising for the further development of in situ targeted drug delivery systems. |
format | Online Article Text |
id | pubmed-10379042 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-103790422023-07-29 New Biopharmaceutical Characteristics of In Situ Systems Based on Poloxamer 407 Bakhrushina, Elena O. Novozhilova, Elizaveta V. Shumkova, Marina M. Pyzhov, Victor S. Nikonenko, Maria S. Bardakov, Alexander I. Demina, Natalia B. Krasnyuk, Ivan I. Krasnyuk, Ivan I. Gels Article Thermosensitive systems based on poloxamer 407 are widely used in targeted drug delivery; however, the stability of the phase transition temperature remains insufficiently studied. This article presents the results of a study on the effect of adding polyethylene glycols (PEG) with different molecular weights and some classical gel-forming polymers on the gelation temperature of thermoreversible compositions based on poloxamer 407 in a long-term experiment. The study showed a positive effect of PEG addition with average molecular weights at concentrations of 1.5–2.0%, as well as gelling agents at a concentration below the critical gelation concentration. The proposed rheological test for studying the samples’ adhesion can give an indirect forecast of the composition adhesive rate. Based on the conducted studies, three experimental binary systems based on poloxamer 407 were selected, with the addition of HPMC 0.5%, sodium alginate 0.5%, and PEG 1500 1.5%. These systems are the most promising for the further development of in situ targeted drug delivery systems. MDPI 2023-06-21 /pmc/articles/PMC10379042/ /pubmed/37504387 http://dx.doi.org/10.3390/gels9070508 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Bakhrushina, Elena O. Novozhilova, Elizaveta V. Shumkova, Marina M. Pyzhov, Victor S. Nikonenko, Maria S. Bardakov, Alexander I. Demina, Natalia B. Krasnyuk, Ivan I. Krasnyuk, Ivan I. New Biopharmaceutical Characteristics of In Situ Systems Based on Poloxamer 407 |
title | New Biopharmaceutical Characteristics of In Situ Systems Based on Poloxamer 407 |
title_full | New Biopharmaceutical Characteristics of In Situ Systems Based on Poloxamer 407 |
title_fullStr | New Biopharmaceutical Characteristics of In Situ Systems Based on Poloxamer 407 |
title_full_unstemmed | New Biopharmaceutical Characteristics of In Situ Systems Based on Poloxamer 407 |
title_short | New Biopharmaceutical Characteristics of In Situ Systems Based on Poloxamer 407 |
title_sort | new biopharmaceutical characteristics of in situ systems based on poloxamer 407 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10379042/ https://www.ncbi.nlm.nih.gov/pubmed/37504387 http://dx.doi.org/10.3390/gels9070508 |
work_keys_str_mv | AT bakhrushinaelenao newbiopharmaceuticalcharacteristicsofinsitusystemsbasedonpoloxamer407 AT novozhilovaelizavetav newbiopharmaceuticalcharacteristicsofinsitusystemsbasedonpoloxamer407 AT shumkovamarinam newbiopharmaceuticalcharacteristicsofinsitusystemsbasedonpoloxamer407 AT pyzhovvictors newbiopharmaceuticalcharacteristicsofinsitusystemsbasedonpoloxamer407 AT nikonenkomarias newbiopharmaceuticalcharacteristicsofinsitusystemsbasedonpoloxamer407 AT bardakovalexanderi newbiopharmaceuticalcharacteristicsofinsitusystemsbasedonpoloxamer407 AT deminanataliab newbiopharmaceuticalcharacteristicsofinsitusystemsbasedonpoloxamer407 AT krasnyukivani newbiopharmaceuticalcharacteristicsofinsitusystemsbasedonpoloxamer407 AT krasnyukivani newbiopharmaceuticalcharacteristicsofinsitusystemsbasedonpoloxamer407 |